In this study, we aimed to determine the circulating levels of IGF-1, IGFBP-2, and IGFBP-3 in patients with CRC and to investigate their association with different clinical aspects of CRC, including risk, tumor grade, and tumor stage. The gene discussed is IGFBP2; the disease is neoplasm.